Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 3 6Phase 4 4Phase 1 4Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 7INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Thymic aplasia 1Small Cell Lung Carcinoma 1Immunologic Deficiency Syndromes 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Blood Specimen Collection × Clear all
NCT06274515 2026-05-06

REMERGE

Hoffmann-La Roche

Phase 4 Recruiting
320 enrolled
Breast

Breast Neoplasms

NCT02274662 2025-01-16

Expanded Access Protocol Thymus Transplantation

Sumitomo Pharma Switzerland GmbH

Phase 4 Completed
11 enrolled 10 charts

Thymic aplasia, Immunologic Deficiency Syndromes

NCT04180176 2024-01-17

PCG

Genentech, Inc.

Phase 4 Completed
945 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT00140036 2008-03-03

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Pfizer

Phase 4 Completed
137 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡